Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

AlzChem adjusts the forecast for fiscal year 2020 due to COVID-19

Trostberg, October 14, 2020 – Due to the continuing economic effects of the COVID-19 pandemic in individual target industries and regions, AlzChem Group AG adjusts its forecast for fiscal year 2020. The continued very positive development, especially for Bioselect® products, which are among other things an essential component of the COVID-19 test kits, cannot fully compensate for these effects.

Therefore, the company now expects to generate stable to slightly declining consolidated sales compared to the previous year (original forecast: slightly rising to sharply rising). A similar development can be expected for adjusted EBITDA (original forecast: stable to sharply rising).

Sabine Sieber

Sabine Sieber

Investor Relations
T +49 8621 86-2888
F +49 8621 86-502888

AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg